HAUS8

gene
On this page

Also known as MGC20533NY-SAR-48

Summary

HAUS8 (HAUS augmin like complex subunit 8, HGNC:30532) is a protein-coding gene on chromosome 19p13.11, encoding HAUS augmin-like complex subunit 8 (Q9BT25). Contributes to mitotic spindle assembly, maintenance of centrosome integrity and completion of cytokinesis as part of the HAUS augmin-like complex. It is a selective cancer dependency (DepMap: 79.7% of cell lines).

HAUS8 is 1 of 8 subunits of the 390-kD human augmin complex, or HAUS complex. The augmin complex was first identified in Drosophila, and its name comes from the Latin verb ‘augmentare,’ meaning ’to increase.’ The augmin complex is a microtubule-binding complex involved in microtubule generation within the mitotic spindle and is vital to mitotic spindle assembly (Goshima et al., 2008 [PubMed 18443220]; Uehara et al., 2009 [PubMed 19369198]).

Source: NCBI Gene 93323 — RefSeq curated summary.

At a glance

  • GWAS associations: 5
  • Clinical variants (ClinVar): 87 total
  • Cancer dependency (DepMap): dependent in 79.7% of screened cell lines
  • MANE Select transcript: NM_033417

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:30532
Approved symbolHAUS8
NameHAUS augmin like complex subunit 8
Location19p13.11
Locus typegene with protein product
StatusApproved
AliasesMGC20533, NY-SAR-48
Ensembl geneENSG00000131351
Ensembl biotypeprotein_coding
OMIM613434
Entrez93323

Gene structure

Transcript identifiers

Ensembl transcripts: 10 — 5 protein_coding, 3 retained_intron, 2 nonsense_mediated_decay

ENST00000253669, ENST00000448593, ENST00000593360, ENST00000595958, ENST00000597479, ENST00000597917, ENST00000598517, ENST00000601564, ENST00000936148, ENST00000936149

RefSeq mRNA: 2 — MANE Select: NM_033417 NM_001011699, NM_033417

CCDS: CCDS32948, CCDS46009

Canonical transcript exons

ENST00000253669 — 11 exons

ExonStartEnd
ENSE000008998341707327417073335
ENSE000013330011707539417075452
ENSE000032044611704972917050176
ENSE000034935801705955717059651
ENSE000034952651705282517052966
ENSE000035112471705881117058876
ENSE000035938411706903117069086
ENSE000036007801706269817062779
ENSE000036476331705999717060092
ENSE000036878081705586117056002
ENSE000036879101705854917058707

Expression profiles

Bgee: expression breadth ubiquitous, 167 present calls, max score 90.81.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 3.4235 / max 88.6392, expressed in 1284 samples.

FANTOM5 promoters (2 alternative TSS)

Promoter IDTPM avgSamples expressed
1798333.34611274
1798320.077439

Top tissues by expression

250 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099190.81gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047387.87gold quality
granulocyteCL:000009487.66gold quality
mucosa of transverse colonUBERON:000499184.28gold quality
right testisUBERON:000453483.64gold quality
left testisUBERON:000453383.35gold quality
ventricular zoneUBERON:000305383.19gold quality
testisUBERON:000047382.42gold quality
ganglionic eminenceUBERON:000402381.85gold quality
spleenUBERON:000210680.42gold quality
secondary oocyteCL:000065580.02gold quality
lymph nodeUBERON:000002979.80gold quality
vermiform appendixUBERON:000115479.67gold quality
lower esophagus mucosaUBERON:003583479.47gold quality
leukocyteCL:000073878.98gold quality
transverse colonUBERON:000115778.88gold quality
right lobe of liverUBERON:000111478.73gold quality
monocyteCL:000057678.53gold quality
bone marrow cellCL:000209278.10gold quality
small intestine Peyer’s patchUBERON:000345477.95gold quality
apex of heartUBERON:000209877.85gold quality
stromal cell of endometriumCL:000225577.55gold quality
left adrenal glandUBERON:000123477.07gold quality
popliteal arteryUBERON:000225076.88gold quality
tibial arteryUBERON:000761076.88gold quality
descending thoracic aortaUBERON:000234576.85gold quality
muscle layer of sigmoid colonUBERON:003580576.85gold quality
left adrenal gland cortexUBERON:003582576.85gold quality
right adrenal glandUBERON:000123376.64gold quality
right adrenal gland cortexUBERON:003582776.63gold quality

Single-cell (SCXA)

Detected in 2 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes4.04
E-MTAB-4850no167.27

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

28 targeting HAUS8, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-548AW99.9972.573559
HSA-MIR-302E99.9670.742669
HSA-MIR-106A-5P99.9073.942683
HSA-MIR-17-5P99.8973.832665
HSA-MIR-302A-3P99.8971.231777
HSA-MIR-302B-3P99.8971.231777
HSA-MIR-302C-3P99.8971.201778
HSA-MIR-302D-3P99.8971.251777
HSA-MIR-106B-5P99.8874.722795
HSA-MIR-20A-5P99.8874.762769
HSA-MIR-20B-5P99.8874.012621
HSA-MIR-519D-3P99.8873.972607
HSA-MIR-526B-3P99.8874.062587
HSA-MIR-93-5P99.8873.982606
HSA-MIR-373-3P99.8470.681668
HSA-MIR-520E-3P99.8470.551698
HSA-MIR-372-3P99.8370.581691
HSA-MIR-520A-3P99.8370.591687
HSA-MIR-520B-3P99.8370.561699
HSA-MIR-520C-3P99.8370.561699
HSA-MIR-520D-3P99.8370.781676
HSA-MIR-360999.5269.892587
HSA-MIR-548AH-5P99.5269.732626
HSA-MIR-142-5P99.4870.922416
HSA-MIR-5590-3P99.4870.912429
HSA-MIR-3140-5P99.3969.041136
HSA-MIR-4796-3P99.0868.381681
HSA-MIR-299-5P98.5671.141140

Functional genomics

DepMap (CRISPR cell-line fitness): dependent in 79.7% of screened cell lines.

Literature-anchored findings (GeneRIF, showing 5)

  • Hice1 is a novel microtubule-associated protein important for maintaining spindle integrity and chromosomal stability, in part by virtue of its ability to bind, bundle, and stabilize microtubules. (PMID:18362163)
  • Results suggest that Hec1, through cooperation with Hice1, contributes to centrosome-directed microtubule growth to facilitate establishing a proper mitotic spindle. (PMID:19776357)
  • Aurora-A modulates the microtubule binding activity of Hice1 in a spatiotemporal manner for proper bipolar spindle assembly. (PMID:21705324)
  • Hice1 and hDgt6 are core components of distinct augmin sub-complexes. (PMID:25173975)
  • these results demonstrated that HAUS8 may function as a positive regulator of RLRVISA dependent antiviral signaling by targeting the VISA complex, providing a novel regulatory mechanism of antiviral responses (PMID:29916539)

Cross-species orthologs

3 orthologs

OrganismSymbolGene ID
danio_reriohaus8ENSDARG00000109646
mus_musculusHaus8ENSMUSG00000035439
rattus_norvegicusHaus8ENSRNOG00000052038

Protein

Protein identifiers

HAUS augmin-like complex subunit 8Q9BT25 (reviewed: Q9BT25)

Alternative names: HEC1/NDC80-interacting centrosome-associated protein 1, Sarcoma antigen NY-SAR-48

All UniProt accessions (3): Q9BT25, M0R1H1, M0R3B3

UniProt curated annotations — full annotation on UniProt →

Function. Contributes to mitotic spindle assembly, maintenance of centrosome integrity and completion of cytokinesis as part of the HAUS augmin-like complex.

Subunit / interactions. Component of the HAUS augmin-like complex. The complex interacts with the gamma-tubulin ring complex and this interaction is required for spindle assembly. Associates with microtubules. The interaction with microtubules is strong during mitosis, while it is weak or absent during interphase. It is unclear whether this interaction is direct or indirect. Interacts with EML3 (phosphorylated at ‘Thr-881’) and TUBG1.

Subcellular location. Cytoplasm. Cytoskeleton. Microtubule organizing center. Centrosome. Spindle. Spindle pole.

Similarity. Belongs to the HAUS8 family.

Isoforms (3)

UniProt IDNamesCanonical?
Q9BT25-11yes
Q9BT25-22
Q9BT25-33

RefSeq proteins (2): NP_001011699, NP_219485* (*=MANE)

Domains & families (InterPro)

UniProt features (20 total): sequence conflict 7, region of interest 3, splice variant 2, compositionally biased region 2, modified residue 2, initiator methionine 1, chain 1, sequence variant 1, coiled-coil region 1

Structure

Experimental structures (PDB)

1 structures.

PDBMethodResolution (Å)
7SQKELECTRON MICROSCOPY8

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q9BT25-F169.890.37

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (2): 2, 105

Function

Pathways and Gene Ontology

Reactome pathways

7 pathways

IDPathway
R-HSA-2565942Regulation of PLK1 Activity at G2/M Transition
R-HSA-380259Loss of Nlp from mitotic centrosomes
R-HSA-380270Recruitment of mitotic centrosome proteins and complexes
R-HSA-380284Loss of proteins required for interphase microtubule organization from the centrosome
R-HSA-380320Recruitment of NuMA to mitotic centrosomes
R-HSA-5620912Anchoring of the basal body to the plasma membrane
R-HSA-8854518AURKA Activation by TPX2

MSigDB gene sets: 204 (showing top): GOBP_REGULATION_OF_PROTEIN_POLYMERIZATION, GOBP_REGULATION_OF_MICROTUBULE_BASED_PROCESS, GOBP_MICROTUBULE_NUCLEATION, GOBP_REGULATION_OF_CELLULAR_COMPONENT_BIOGENESIS, GOCC_MICROTUBULE_ORGANIZING_CENTER, GOBP_REGULATION_OF_MICROTUBULE_POLYMERIZATION, GOCC_CENTROSOME, GOBP_REGULATION_OF_PROTEIN_CONTAINING_COMPLEX_ASSEMBLY, GOBP_ORGANELLE_ASSEMBLY, FISCHER_DREAM_TARGETS, GOBP_SPINDLE_ASSEMBLY, GOBP_REGULATION_OF_MICROTUBULE_POLYMERIZATION_OR_DEPOLYMERIZATION, GOBP_REGULATION_OF_CYTOSKELETON_ORGANIZATION, GOBP_MICROTUBULE_POLYMERIZATION, GOCC_SPINDLE

GO Biological Process (4): centrosome cycle (GO:0007098), regulation of microtubule nucleation (GO:0010968), spindle assembly (GO:0051225), cell division (GO:0051301)

GO Molecular Function (2): microtubule binding (GO:0008017), protein binding (GO:0005515)

GO Cellular Component (10): spindle pole (GO:0000922), cytoplasm (GO:0005737), centrosome (GO:0005813), cytosol (GO:0005829), nuclear microtubule (GO:0005880), HAUS complex (GO:0070652), mitotic spindle microtubule (GO:1990498), spindle (GO:0005819), cytoskeleton (GO:0005856), microtubule (GO:0005874)

Reactome top-level categories

Rollup of top-5 pathways:

CategoryPathways
G2/M Transition2
Centrosome maturation2
Loss of proteins required for interphase microtubule organization from the centrosome1
Mitotic Prometaphase1
Assembly of the 9+0 primary cilium1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cellular anatomical structure3
microtubule cytoskeleton2
intracellular membraneless organelle2
cell cycle process1
microtubule organizing center organization1
microtubule nucleation1
regulation of microtubule polymerization1
spindle organization1
chromosome segregation1
membraneless organelle assembly1
cellular process1
tubulin binding1
binding1
spindle1
intracellular anatomical structure1
centriole1
microtubule organizing center1
cytoplasm1
nucleus1
microtubule1
microtubule associated complex1
spindle microtubule1
mitotic spindle1
polymeric cytoskeletal fiber1

Protein interactions and networks

STRING

930 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
HAUS8HAUS6Q7Z4H7977
HAUS8HAUS3Q68CZ6824
HAUS8HAUS1Q96CS2781
HAUS8NDC80O14777770
HAUS8HAUS7Q99871758
HAUS8TUBG1P23258754
HAUS8HAUS5O94927743
HAUS8HAUS4Q9H6D7703
HAUS8NUMA1Q14980703
HAUS8HAUS2Q9NVX0678
HAUS8NEDD1Q8NHV4669
HAUS8GPR137CQ8N3F9522
HAUS8ULK4Q96C45517
HAUS8FBXO47Q5MNV8456
HAUS8SYCE2Q6PIF2453

IntAct

200 interactions, top by confidence:

ABTypeScore
CEP97CCP110psi-mi:“MI:2364”(proximity)0.950
MED4MED19psi-mi:“MI:2364”(proximity)0.900
CEP290CCP110psi-mi:“MI:2364”(proximity)0.890
HAUS2HAUS6psi-mi:“MI:0915”(physical association)0.880
HAUS6HAUS8psi-mi:“MI:0915”(physical association)0.850
HAUS6HAUS8psi-mi:“MI:0407”(direct interaction)0.850
HAUS8HAUS6psi-mi:“MI:0407”(direct interaction)0.850
HAUS1HAUS6psi-mi:“MI:0915”(physical association)0.810
HAUS1HAUS5psi-mi:“MI:0915”(physical association)0.780
HAUS1HAUS5psi-mi:“MI:0914”(association)0.780
HAUS2HAUS5psi-mi:“MI:0914”(association)0.730
HAUS6HAUS5psi-mi:“MI:0914”(association)0.710
CFTRESYT2psi-mi:“MI:0914”(association)0.710
CEP170KIF2Apsi-mi:“MI:2364”(proximity)0.650
HAUS4HAUS5psi-mi:“MI:0914”(association)0.640
Haus4HAUS5psi-mi:“MI:0914”(association)0.560

BioGRID (175): HAUS8 (Affinity Capture-MS), HAUS8 (Affinity Capture-MS), HAUS8 (Affinity Capture-MS), HAUS8 (Affinity Capture-MS), HAUS8 (Two-hybrid), HAUS8 (Proximity Label-MS), HAUS8 (Proximity Label-MS), HAUS8 (Proximity Label-MS), HAUS8 (Proximity Label-MS), HAUS8 (Proximity Label-MS), HAUS8 (Proximity Label-MS), HAUS8 (Proximity Label-MS), HAUS8 (Proximity Label-MS), HAUS8 (Proximity Label-MS), HAUS8 (Proximity Label-MS)

ESM2 similar proteins: A0A059XKS9, A0A125YS36, A0A125YYR0, A0A7J6K144, A0A7J6K7I9, A0A7J6K7Y0, A4HK17, A4I7K1, B5APK2, B9Q0C2, E9PSU6, F2YGR7, F4IVL6, F6N7K6, O04064, O48767, P0CH66, P23915, P24686, Q2PAY2, Q2PAY3, Q384Y0, Q387Y5, Q388F1, Q40504, Q40505, Q4CTY5, Q4D7L5, Q4DHA1, Q4Q5P8, Q57XK8, Q57XV5, Q580X6, Q5R4R7, Q6B9Y8, Q6GV23, Q75CM4, Q80TL4, Q84VW5, Q8L5Y5

Diamond homologs: Q0IHJ3, Q99L00, Q9BT25, Q5BK57

SIGNOR signaling

1 interactions.

AEffectBMechanism
HAUS8“form complex”“HAUS complex”binding

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 165 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

Reactome pathways:

PathwayPartnersFoldFDR
Anchoring of the basal body to the plasma membrane2729.1×2e-30
Loss of Nlp from mitotic centrosomes1928.7×4e-21
Loss of proteins required for interphase microtubule organization from the centrosome1928.7×4e-21
AURKA Activation by TPX21927.6×8e-21
Recruitment of mitotic centrosome proteins and complexes2025.9×4e-21
Regulation of PLK1 Activity at G2/M Transition1923.0×2e-19
Recruitment of NuMA to mitotic centrosomes2022.2×5e-20
Centrosome maturation614.5×2e-04

GO biological processes:

GO termPartnersFoldFDR
centriole replication945.5×1e-10
centrosome cycle1023.2×3e-09
spindle assembly721.4×4e-06
non-motile cilium assembly1020.0×1e-08
motile cilium assembly520.0×4e-04
cilium assembly189.1×3e-10
intracellular protein localization107.2×1e-04
cell division185.7×4e-07

Disease & clinical

Clinical variants and AI predictions

ClinVar

87 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance62
Likely benign4
Benign2

Top pathogenic / likely-pathogenic (0)

SpliceAI

2007 predictions. Top by Δscore:

VariantEffectΔscore
19:17052820:GGTAC:Gdonor_loss1.0000
19:17052823:ACCTT:Adonor_loss1.0000
19:17052836:AAGGT:Adonor_gain1.0000
19:17052858:T:TAdonor_gain1.0000
19:17052964:CGT:Cacceptor_gain1.0000
19:17055859:ACCT:Adonor_loss1.0000
19:17055860:C:CTdonor_loss1.0000
19:17055915:G:Adonor_gain1.0000
19:17055999:CGAT:Cacceptor_gain1.0000
19:17056000:GAT:Gacceptor_gain1.0000
19:17056002:TCT:Tacceptor_loss1.0000
19:17056003:C:CCacceptor_gain1.0000
19:17056003:C:Tacceptor_loss1.0000
19:17058540:A:ACdonor_gain1.0000
19:17058541:C:CCdonor_gain1.0000
19:17058541:CAA:Cdonor_gain1.0000
19:17058581:T:TAdonor_gain1.0000
19:17058878:T:Cacceptor_gain1.0000
19:17059652:C:CCacceptor_gain1.0000
19:17073269:CTTA:Cdonor_loss1.0000
19:17073270:TTAC:Tdonor_loss1.0000
19:17073271:TA:Tdonor_loss1.0000
19:17073332:CTTC:Cacceptor_gain1.0000
19:17073333:TTC:Tacceptor_gain1.0000
19:17073334:TC:Tacceptor_gain1.0000
19:17073334:TCC:Tacceptor_loss1.0000
19:17073335:CC:Cacceptor_gain1.0000
19:17073336:C:CCacceptor_gain1.0000
19:17073336:C:Gacceptor_loss1.0000
19:17073337:T:Aacceptor_loss1.0000

AlphaMissense

2661 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
19:17069063:A:CY39D0.985
19:17069063:A:GY39H0.983
19:17055933:C:GA239P0.982
19:17058674:C:GA174P0.982
19:17055908:A:GL247P0.979
19:17055929:A:GL240P0.978
19:17058846:A:GS151P0.978
19:17069062:T:GY39S0.977
19:17050130:C:GA326P0.976
19:17050153:A:GL318P0.976
19:17058830:A:GL156P0.976
19:17052831:A:GL308P0.975
19:17055938:G:TA237D0.974
19:17055951:A:CY233D0.973
19:17050127:C:GA327P0.972
19:17055939:C:GA237P0.972
19:17058836:A:GL154P0.972
19:17060057:A:GS89P0.972
19:17058821:A:GL159P0.971
19:17069059:A:GL40P0.967
19:17069063:A:TY39N0.967
19:17069062:T:CY39C0.966
19:17050137:G:CS323R0.965
19:17050137:G:TS323R0.965
19:17050139:T:GS323R0.965
19:17055926:T:AD241V0.964
19:17058824:A:GL158P0.963
19:17060002:A:TI107N0.963
19:17060053:G:TT90K0.962
19:17069066:G:CR38G0.962

dbSNP variants (sampled 300 via entrez): RS1000007759 (19:17069713 C>T), RS1000015982 (19:17070362 C>T), RS1000077348 (19:17073265 A>G), RS1000233578 (19:17061991 A>G), RS1000244382 (19:17067577 G>C), RS1000406227 (19:17077513 C>T), RS1000579932 (19:17066270 A>T), RS1000747911 (19:17076325 G>A), RS1000804311 (19:17051444 G>A,C,T), RS1000835335 (19:17051784 T>C), RS1000970963 (19:17071183 T>G), RS1000996019 (19:17057365 T>A), RS1001059744 (19:17050963 G>A), RS1001117057 (19:17062659 C>A,T), RS1001144794 (19:17062879 T>C)

Disease associations

OMIM: gene MIM:613434 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

5 associations (top):

StudyTraitp-value
GCST003814_3Selective IgA deficiency2.000000e-07
GCST004863_38Mosquito bite size5.000000e-06
GCST90002391_108Mean corpuscular hemoglobin concentration8.000000e-09
GCST90020025_1420Waist-to-hip ratio adjusted for BMI4.000000e-10
GCST90020027_132Waist-hip index4.000000e-10

EFO canonical traits (3, from GWAS)

EFO IDTrait name
EFO:0008378mosquito bite reaction size measurement
EFO:0004528mean corpuscular hemoglobin concentration
EFO:0007788BMI-adjusted waist-hip ratio

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

40 total (human), top 30 by PubMed support.

ChemicalActions (top 5)PubMed papers
bisphenol Aaffects expression, increases abundance, decreases expression, affects cotreatment2
Resveratrolincreases expression, affects cotreatment2
3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamidedecreases expression1
FR900359decreases phosphorylation1
ginger extractaffects expression, increases abundance, affects cotreatment1
tris(1,3-dichloro-2-propyl)phosphatedecreases expression1
sodium arseniteincreases expression1
perfluorooctanoic aciddecreases expression1
zinc chromatedecreases expression, increases abundance1
benzo(e)pyreneincreases methylation1
di-n-butylphosphoric acidaffects expression1
chromium hexavalent iondecreases expression, increases abundance1
CGP 52608affects binding, increases reaction1
jinfukangincreases expression1
Temozolomideincreases expression1
Sunitinibdecreases expression1
Leflunomidedecreases expression1
Atrazinedecreases expression1
Benzo(a)pyreneaffects methylation1
Caffeineincreases phosphorylation1
Calcitrioldecreases expression, affects cotreatment1
Coumestrolaffects cotreatment, increases expression1
Dimethyl Sulfoxideincreases expression1
Ivermectindecreases expression1
Leadaffects expression1
Methapyrileneincreases methylation1
Methyl Methanesulfonateincreases expression1
Mustard Gasdecreases expression1
Oils, Volatileaffects cotreatment, affects expression, increases abundance1
Oxygendecreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

  • Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): selective IgA deficiency disease